nach oben

Erschienen in:

06.11.2021 | Original Article

Vaginal pessary in advanced pelvic organ prolapse: impact on quality of life

verfasst von: Barbara Bevilacqua Zeiger, Silvia da Silva Carramão, Carlos Antônio Del Roy, Thais Travassos da Silva, Susane Mei Hwang, Antonio Pedro Flores Auge

Erschienen in: International Urogynecology Journal | Ausgabe 7/2022

Einloggen, um Zugang zu erhalten

Abstract

Introduction and hypothesis

Pelvic organ prolapse (POP) is a highly prevalent dysfunction of the pelvic floor affecting up to 40% of women. The symptoms of POP have a major impact on quality of life. Pessary treatment is a therapy option associated with high levels of satisfaction and few complications.

Objectives

The objective was to assess the impact and efficacy of vaginal pessary use on the quality of life of women with advanced POP stages III and IV.

Materials and methods

A multicenter, longitudinal, prospective observational study was conducted at the Urogynecology Sector of the Hospital Ipiranga and the Hospital Central of the Irmandade da Santa Casa de Misericórdia de São Paulo. A sociodemographic questionnaire was employed and two scales validated in Portuguese (ICIQVS and SF 12) were applied before and 6 months after pessary use. Student´s t test, Mann–Whitney test and Fisher´s exact test were applied, adopting a significance level of 0.05.

Results

The median age of participants was 71.5 (65–76) years and the median number of pregnancies was 4 (3–5). Deliveries were predominantly vaginal (82.5%). Women sexually active (16.49%) showed improvement in sexual function (78.6%). The participants showed improvement in vaginal symptoms (91.8%) and quality of life (92.8%) (p < 0.01) post-treatment. Of the total 97 women, the sample drop-out rate was 9.3% and 88 participants completed the two stages of the study.

Conclusions

Vaginal pessary use had 90.7% efficacy, a high level of treatment satisfaction (75.3%), and a positive impact on the improvement of vaginal and sexual symptoms, quality of life, and mental health.

Jelovsek JE, Barber MD. Women seeking treatment for advanced pelvic organ prolapse have decreased body image and quality of life. Am J Obstet Gynecol. 2006;194(5):1455–61. https://doi.org/10.1016/j.ajog.2006.01.060.CrossRefPubMed

Subak LL, Waetjen LE, van den Eeden S, Thom DH, Vittinghoff E, Brown JS. Cost of pelvic organ prolapse surgery in the United States. Obstet Gynecol. 2001;98(4):646–51. https://doi.org/10.1016/s0029-7844(01)01472-7.CrossRefPubMed

Boyles SH, Weber AM, Meyn L. Procedures for pelvic organ prolapse in the United States, 1979–1997. Am J Obstet Gynecol. 2003;188(1):108–15. https://doi.org/10.1067/mob.2003.101.CrossRefPubMed

DeLancey JOL. The hidden epidemic of pelvic floor dysfunction: achievable goals for improved prevention and treatment. Am J Obstet Gynecol. 2005;192(5):1488–95. https://doi.org/10.1016/j.ajog.2005.02.028.CrossRefPubMed

DATASUS. Demográficas e socioeconômicas. http://datasus.saude.gov.br/informacoes-de-saude/tabnet/demograficas-e-socioeconomicas. 2000.

Silva Filho AL, Fonseca AMRM, Camilatto ES, Cangussu RO. Análise dos recursos para reabilitação da musculatura do assoalho pélvico em mulheres com prolapso e incontinência urinária. Fisioter Pes. 2013;20(1):90–6. https://doi.org/10.1590/S1809-29502013000100015.CrossRef

Instituto Brasileiro de Geografia e Estatística (IBGE), Fundo de População das Nações Unidas (UNFPA). Indicadores sociodemográficos prospectivos para o Brasil 1991–2030. 2006. http://www.unfpa.org.br/Arquivos/PDS_Sociodemographic_indicators.pdfgov.br/home/estatistica/populacao/projecao_da_populacao/ publicacao_UNFPA.pdf. Acessed 5 Feb 2008.

Petros P. The integral system. Cent European J Urol. 2011;64(3):110–9.CrossRef

Haylen BT, Maher CF, Barber MD, Camargo S, Dandolu V, Digesu A, et al. An International Urogynecological Association (IUGA)/International Continence Society (ICS) joint report on the terminology for female pelvic organ prolapse (POP). Int Urogynecol J. 2016;27(2):165–94.CrossRef

10.

Büyükbayrak EE, Yilmazer G, Özyapi AG, Kars B, Karsidag AYK, Turan C. Successful management of uterine prolapse during pregnancy with vaginal pessary: a case report. J Turk Ger Gynecol Assoc. 2010;11(2):105–6.CrossRef

11.

Lamers BHC, Broekman BMW, Milani AL. Pessary treatment for pelvic organ prolapse and health-related quality of life: a review. Int Urogynecol J. 2011;22(6):637–44. https://doi.org/10.1007/s00192-011-1390-7.CrossRefPubMedPubMedCentral

12.

Teixeira AS. Faculdade de educação e meio ambiente, pp 1–45. 2011.

13.

Coelho SCA, Giraldo PC, Florentino JO, de Castro ED, Brito LGO, Juliato CRT. O uso de pessário vaginal pode alterar a flora microbiológica? Um estudo transversal. Rev Bras Ginecol Obstet. 2017;39(4):169–74.CrossRef

14.

McIntosh L. The role of the nurse in the use of vaginal pessaries to treat pelvic organ prolapse and/or urinary incontinence: a literature review. Urol Nurs. 2005;25(1):41–8.PubMed

15.

Patel M, Mellen C, O’Sullivan DM, LaSala CA. Impact of pessary use on prolapse symptoms, quality of life, and body image. Am J Obstet Gynecol. 2010;202(5):499.e1–.e4. https://doi.org/10.1016/j.ajog.2010.01.019

16.

Coelho SCA, de Castro EB, Juliato CRT. Female pelvic organ prolapse using pessaries: systematic review. Int Urogynecol J. 2016;27(2):1797–803. https://doi.org/10.1007/s00192-016-2991-y.CrossRef

17.

Mao M, Ai F, Kang J, Zhang Y, Liang S, Zhou Y, Zhu L. Successful long-term use of Gellhorn pessary and the effect on symptoms and quality of life in women with symptomatic pelvic organ prolapse. Menopause. 2009;26(2):145–51. https://doi.org/10.1097/GME.0000000000001197.CrossRef

18.

Silva CHM. Manual SOGIMIG de Uroginecologia. 1st ed. Rio de Janeiro: Med Book; 2019. p. 145–55.

19.

Bump RC, Mattiasson A, Bø K, et al. The standardization of terminology of female pelvic organ prolapse and pelvic organ dysfunction. Am J Obstet Gynecol. 1996;175(1):10–7.CrossRef

20.

Tamanini JTN, Almeida FG, Girotti ME, Riccetto CLZ, Palma PCR, Rios LAS, et al. The Portuguese validation of the International Consultation on Incontinence Questionnaire-Vaginal Symptoms (ICIQ-VS) for Brazilian women with pelvic organ prolapse. Int Urogynecol J. 2008;19(10):1385–91. https://doi.org/10.1007/s00192-008-0641-8.CrossRef

21.

Silveira MF, Almeida JC, Freire RS, Haikal DS, Martins AEBL. Psychometric properties of the quality of life assessment instrument: 12-item health survey (SF-12). Ciên Saúde Colet. 2013;18(7):1923–31. https://doi.org/10.1590/s1413-81232013000700007.CrossRefPubMed

22.

Clemons JL, Aguilar VC, Tillinghast TA, Jackson ND, Myers DL. Patient satisfaction and changes in prolapse and urinary symptoms in women who were fitted successfully with a pessary for pelvic organ prolapse. Am J Obstet Gynecol. 2004;190(4):1025–9. https://doi.org/10.1016/j.ajog.2003.10.711.CrossRefPubMed

23.

Fernando RJ, Thakar R, Sultan AH, Shah SM, Jones PW. Effect of vaginal pessaries on symptoms associated with pelvic organ prolapse. Obstet Gynecol. 2006;108(1):93–9. https://doi.org/10.1097/01.AOG.0000222903.38684.cc.CrossRefPubMed

24.

Maito JM, Quam ZA, Craig E, Danner KA, Rogers RG. Predictors of successful pessary fitting and continued use in a nurse-midwifery pessary clinic. J Midwifery Womens Health. 2006;51(2):78–84. https://doi.org/10.1016/j.jmwh.2005.09.003.CrossRefPubMed

25.

Barros CR, Machado RBB, Camargo ACM, Gollop TR. Tratamento conservador de prolapso de órgão pélvico com pessário: revisão de literatura. Rev Med. 2018;97(2):154–9. https://doi.org/10.11606/issn.1679-9836.v97i2p154-159.CrossRef

Titel: Vaginal pessary in advanced pelvic organ prolapse: impact on quality of life
verfasst von: Barbara Bevilacqua Zeiger
Silvia da Silva Carramão
Carlos Antônio Del Roy
Thais Travassos da Silva
Susane Mei Hwang
Antonio Pedro Flores Auge
Publikationsdatum: 06.11.2021
Verlag: Springer International Publishing
Erschienen in: International Urogynecology Journal / Ausgabe 7/2022
Print ISSN: 0937-3462
Elektronische ISSN: 1433-3023
DOI: https://doi.org/10.1007/s00192-021-05002-7

Neu im Fachgebiet Gynäkologie und Geburtshilfe

Alter der Mutter beeinflusst Risiko für kongenitale Anomalie

28.05.2024 Kinder- und Jugendgynäkologie Nachrichten

Welchen Einfluss das Alter ihrer Mutter auf das Risiko hat, dass Kinder mit nicht chromosomal bedingter Malformation zur Welt kommen, hat eine ungarische Studie untersucht. Sie zeigt: Nicht nur fortgeschrittenes Alter ist riskant.

Fehlerkultur in der Medizin – Offenheit zählt!

28.05.2024 Fehlerkultur Podcast

Darüber reden und aus Fehlern lernen, sollte das Motto in der Medizin lauten. Und zwar nicht nur im Sinne der Patientensicherheit. Eine negative Fehlerkultur kann auch die Behandelnden ernsthaft krank machen, warnt Prof. Dr. Reinhard Strametz. Ein Plädoyer und ein Leitfaden für den offenen Umgang mit kritischen Ereignissen in Medizin und Pflege.

Mammakarzinom: Brustdichte beeinflusst rezidivfreies Überleben

26.05.2024 Mammakarzinom Nachrichten

Frauen, die zum Zeitpunkt der Brustkrebsdiagnose eine hohe mammografische Brustdichte aufweisen, haben ein erhöhtes Risiko für ein baldiges Rezidiv, legen neue Daten nahe.

Mehr Lebenszeit mit Abemaciclib bei fortgeschrittenem Brustkrebs?

24.05.2024 Mammakarzinom Nachrichten

In der MONARCHE-3-Studie lebten Frauen mit fortgeschrittenem Hormonrezeptor-positivem, HER2-negativem Brustkrebs länger, wenn sie zusätzlich zu einem nicht steroidalen Aromatasehemmer mit Abemaciclib behandelt wurden; allerdings verfehlte der numerische Zugewinn die statistische Signifikanz.

Update Gynäkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert – ganz bequem per eMail.

Newsletter bestellen

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Vaginal pessary in advanced pelvic organ prolapse: impact on quality of life